Literature DB >> 2317569

IgG replacement therapy for primary hypogammaglobulinaemia during pregnancy: report of 9 pregnancies in 4 patients.

P E Williams1, C L Leen, A D Heppleston, P L Yap.   

Abstract

We report the cases of four pregnant women with primary hypogammaglobulinaemia, who received intramuscular, intravenous or no replacement therapy with IgG in late pregnancy, and review the literature. Intravenous replacement administered to the mother during pregnancy produces adequate serum IgG levels in the neonate, and should be the treatment of choice in this situation.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2317569     DOI： 10.1007/bf01720276

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


  18 in total

1.  Immunological maturation in an infant of an agammaglobulinaemic mother.

Authors:  N H Holland; P Holland
Journal:  Lancet       Date:  1966-11-26       Impact factor: 79.321

2.  IgG subclasses and antibodies to group B streptococci, pneumococci, and tetanus toxoid in preterm neonates after intravenous infusion of immunoglobulin to the mothers.

Authors:  A Morell; D Sidiropoulos; U Herrmann; K K Christensen; P Christensen; K Prellner; H Fey; F Skvaril
Journal:  Pediatr Res       Date:  1986-10       Impact factor: 3.756

3.  Common variable hypogammaglobulinemia in pregnancy: treatment with high-dose immunoglobulin infusions.

Authors:  D L Madsen; V A Catanzarite; F Varela-Gittings
Journal:  Am J Hematol       Date:  1986-03       Impact factor: 10.047

4.  Hypogammaglobulinaemia during pregnancy in identical twin sisters.

Authors:  Z O Amarin; K A Grant
Journal:  Int J Gynaecol Obstet       Date:  1982-12       Impact factor: 3.561

5.  Use of intravenous immune globulin in pregnant women with common variable hypogammaglobulinemia.

Authors:  R U Sorensen; J W Tomford; M T Gyves; N E Judge; S H Polmar
Journal:  Am J Med       Date:  1984-03-30       Impact factor: 4.965

6.  Increase of serum immunoglobulin level into the normal range in primary hypogammaglobulinaemia by dosage individualization of intravenous immunoglobulin.

Authors:  C L Leen; P L Yap; D B McClelland
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

7.  Salmonellosis in patients with primary hypogammaglobulinaemia.

Authors:  C L Leen; A D Birch; R P Brettle; P D Welsby; P L Yap
Journal:  J Infect       Date:  1986-05       Impact factor: 6.072

8.  Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections.

Authors:  M Ballow; K L Cates; J C Rowe; C Goetz; C Desbonnet
Journal:  Pediatr Res       Date:  1986-09       Impact factor: 3.756

9.  Selective immunodeficiency affecting staphylococcal response.

Authors:  M Monteil; J Hobbs; K Citron
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

10.  High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy.

Authors:  M Berger; T R Cupps; A S Fauci
Journal:  JAMA       Date:  1982-05-28       Impact factor: 56.272
View more
  5 in total

1.  Intravenous immunoglobulin replacement therapy for common variable immunodeficiency during pregnancy.

Authors:  H Osada; Y Morikawa; T Nishiwaki; S Sekiya
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

2.  Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women.

Authors:  A Gardulf; E Andersson; M Lindqvist; S Hansen; R Gustafson
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

3.  Pregnancy Outcome in Patients with Common Variable Immunodeficiency.

Authors:  Pavlina Kralickova; Barbora Kurecova; Ctirad Andrys; Irena Krcmova; Dalibor Jilek; Marcela Vlkova; Jiri Litzman
Journal:  J Clin Immunol       Date:  2015-08-18       Impact factor: 8.317

4.  Fertility, pregnancies and outcomes reported by females with common variable immune deficiency and hypogammaglobulinemia: results from an internet-based survey.

Authors:  Adi V Gundlapalli; Christopher Scalchunes; Marcia Boyle; Harry R Hill
Journal:  J Clin Immunol       Date:  2015-01-09       Impact factor: 8.317

5.  II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.

Authors:  Ekaterini Simões Goudouris; Almerinda Maria do Rego Silva; Aluce Loureiro Ouricuri; Anete Sevciovic Grumach; Antonio Condino-Neto; Beatriz Tavares Costa-Carvalho; Carolina Cardoso Prando; Cristina Maria Kokron; Dewton de Moraes Vasconcelos; Fabíola Scancetti Tavares; Gesmar Rodrigues Silva Segundo; Irma Cecília Barreto; Mayra de Barros Dorna; Myrthes Anna Barros; Wilma Carvalho Neves Forte
Journal:  Einstein (Sao Paulo)       Date:  2017
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.